|
IL126843A
(en)
*
|
1996-05-23 |
2007-06-17 |
Scripps Research Inst |
Mhc class ii antigen-presenting systems and methods for activating cd4+t cells in vitro
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
CA2330678C
(en)
|
1998-05-11 |
2009-04-07 |
Miltenyi Biotec Gmbh |
Method of direct selection of antigen-specific t cells
|
|
US6230662B1
(en)
|
1998-06-22 |
2001-05-15 |
Theresa Miale |
Animal lift and transport apparatus and method for using the same
|
|
CA2340085A1
(en)
*
|
1998-08-10 |
2000-02-24 |
Chiron Corporation |
Engineered antigen-presenting cells expressing an array of antigens and uses thereof
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
DE69942100D1
(de)
*
|
1998-10-20 |
2010-04-15 |
Androclus Technologies S R L I |
Künstliche antigen-spezifischen zellen und zugehörige verfahren
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US7541429B2
(en)
|
2000-10-10 |
2009-06-02 |
The Board Of Regents Of The University Of Oklahoma |
Comparative ligand mapping from MHC positive cells
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
DE10009341A1
(de)
*
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US7541184B2
(en)
*
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
AU2000243137A1
(en)
*
|
2000-04-20 |
2001-11-07 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002056908A2
(en)
*
|
2001-01-16 |
2002-07-25 |
Hildebrand William H |
Artificial antigen-presenting cells
|
|
US7579007B2
(en)
*
|
2001-02-13 |
2009-08-25 |
Jdm Technologies, Inc. |
Production of “biological carriers” for induction of immune responses and inhibition of viral replication
|
|
ES2306771T3
(es)
*
|
2001-02-20 |
2008-11-16 |
Ortho Mcneil Pharm Inc |
Un metodo de terapia celular para tratamiento de tumores.
|
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
FR2824567B1
(fr)
*
|
2001-05-11 |
2003-08-08 |
Inst Nat Sante Rech Med |
Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
|
|
WO2003057171A2
(en)
*
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
*
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US7638326B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US20040072262A1
(en)
*
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
EP1408106B1
(en)
|
2002-10-11 |
2007-02-14 |
Sentoclone Therapeutics AB |
Cancer immuno-therapy
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
WO2005047902A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Beckman Coulter, Inc. |
Solution-based methods for detecting mhc-binding peptides
|
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
|
JP2007525225A
(ja)
|
2004-02-26 |
2007-09-06 |
イミュノバティブ セラピーズ， リミテッド |
細胞治療のためのｔ細胞を調製するための方法
|
|
EP1766393A4
(en)
*
|
2004-05-07 |
2008-06-18 |
Beckman Coulter Inc |
MHC-BRIDGE SYSTEM FOR DETECTION OF THE CTL-MEDIATED LYSE OF ANTIGEN-PRESENTING CELLS
|
|
AU2005250408B2
(en)
|
2004-05-27 |
2010-09-23 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
EP2226332A1
(en)
*
|
2004-06-17 |
2010-09-08 |
Beckman Coulter, Inc. |
Mycobacterium tuberculosis epitopes and methods of use thereof
|
|
EP1712615A1
(en)
*
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
DK1907000T4
(da)
|
2005-06-08 |
2020-03-30 |
The President And Fellows Of Harvard College |
Fremgangsmåder og sammensætninger til behandling af persisterende HIV-infektioner ved hæmning af reaktionsvejen for programmeret celledød 1 (PD-1).
|
|
WO2006138449A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Wistar Institute |
Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
|
|
WO2007071390A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Method for treating malignant melanoma
|
|
JP5205275B2
(ja)
|
2005-12-21 |
2013-06-05 |
セントクローネ インターナショナル エービー |
散在性ガンの治療法
|
|
US8101173B2
(en)
|
2005-12-21 |
2012-01-24 |
Sentoclone International Ab |
Method for treating urinary bladder cancer
|
|
CA2634167C
(en)
|
2005-12-21 |
2015-06-16 |
Sentoclone Ab |
Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer
|
|
CA2643337C
(en)
*
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
CN101548008B
(zh)
*
|
2006-10-04 |
2013-04-17 |
詹森药业有限公司 |
失活的人工抗原提呈细胞的制备及其在细胞疗法中的用途
|
|
CA2673870A1
(en)
*
|
2006-12-27 |
2008-07-10 |
Emory University |
Compositions and methods for the treatment of infections and tumors
|
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
|
MX2011005691A
(es)
|
2008-11-28 |
2011-07-20 |
Univ Emory |
Metodos para el tratamiento de infecciones y tumores.
|
|
US8075895B2
(en)
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
EP2404618A1
(en)
|
2010-07-07 |
2012-01-11 |
Stichting Katholieke Universiteit meer in het bijzonder Radboud Universiteit Nijmegen |
Immunomodulatory protein constructs with a helical polymeric backbone.
|
|
AU2011287108B2
(en)
*
|
2010-08-06 |
2014-08-28 |
Canine-Lab.Inc. |
Immunological function enhancing agent
|
|
SG194753A1
(en)
|
2011-05-03 |
2013-12-30 |
Immunovative Therapies Ltd |
Induction of il-12 using immunotherapy
|
|
KR102229108B1
(ko)
|
2011-05-03 |
2021-03-18 |
이뮤노베이티브 테라피스, 엘티디. |
생세포를 포함하는 생물학적 약물을 처리하기 위한 방법
|
|
WO2013163171A1
(en)
|
2012-04-24 |
2013-10-31 |
Kaufman Dan S |
Method for developing natural killer cells from stem cells
|
|
EP2997134B1
(en)
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
KR102467982B1
(ko)
|
2013-12-16 |
2022-11-16 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
Vlp-레플리콘을 이용한 클래스 ii mhc 항원의 전달에 의한 암 면역요법
|
|
DK3105335T3
(da)
|
2014-02-14 |
2020-01-13 |
Univ Texas |
Kimære antigenreceptorer og fremgangsmåder til fremstilling heraf
|
|
WO2015148960A1
(en)
|
2014-03-28 |
2015-10-01 |
The Board Of Regents Of The University Of Oklahoma |
Compositions comprising soluble hla/m. tuberculosis-specific ligand complexes and methods of production and use thereof
|
|
US20170158749A1
(en)
|
2014-04-23 |
2017-06-08 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) and methods for making and using the same
|
|
KR20160145186A
(ko)
|
2014-04-24 |
2016-12-19 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
CA2964785A1
(en)
|
2014-11-05 |
2016-05-12 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
FR3031519B1
(fr)
|
2015-01-14 |
2016-12-30 |
Arkema France |
Composition a base de terpolymere electroactif
|
|
DK3271382T3
(da)
*
|
2015-03-16 |
2020-05-04 |
Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft |
Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek
|
|
WO2017075147A1
(en)
|
2015-10-27 |
2017-05-04 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
CN118652336A
(zh)
|
2016-06-08 |
2024-09-17 |
普瑞赛格恩公司 |
Cd33特异性嵌合抗原受体
|
|
MA45784A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Anticorps anti-idiotypes dirigés contre anti-cd19 anticorps
|
|
US11883430B2
(en)
|
2016-11-09 |
2024-01-30 |
Musc Foundation For Research Development |
CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy
|
|
CA3049652A1
(en)
|
2017-01-10 |
2018-07-19 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
US11285196B2
(en)
|
2017-03-13 |
2022-03-29 |
Eslam Abbas Baseuny |
Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
|
|
CN110891967B
(zh)
|
2017-04-18 |
2025-03-14 |
富士胶片细胞动力公司 |
抗原特异性免疫效应细胞
|
|
JP2020517259A
(ja)
|
2017-04-19 |
2020-06-18 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
操作された抗原受容体を発現する免疫細胞
|
|
EP3635132A4
(en)
|
2017-06-07 |
2021-05-26 |
Intrexon Corporation |
EXPRESSION OF NOVEL CELL MARKERS
|
|
WO2019075385A1
(en)
|
2017-10-12 |
2019-04-18 |
Board Of Regents, The University Of Texas System |
T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
AU2019386140B2
(en)
|
2018-11-28 |
2026-05-28 |
Board Of Regents, The University Of Texas System |
Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
|
|
EP3886874B1
(en)
|
2018-11-29 |
2024-12-11 |
Board of Regents, The University of Texas System |
Methods for ex vivo expansion of natural killer cells and use thereof
|
|
CN120605327A
(zh)
|
2019-11-06 |
2025-09-09 |
贝勒医学院 |
用于产生细胞毒性效应子记忆t细胞以用于癌症的t细胞治疗的方法
|
|
WO2021163191A1
(en)
|
2020-02-10 |
2021-08-19 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
AU2021278356A1
(en)
|
2020-05-27 |
2022-11-03 |
Antion Biosciences Sa |
Adapter molecules to re-direct CAR T cells to an antigen of interest
|
|
WO2022140759A2
(en)
|
2020-12-23 |
2022-06-30 |
Janssen Biotech, Inc. |
Neoantigen peptide mimics
|
|
WO2023211972A1
(en)
|
2022-04-28 |
2023-11-02 |
Medical University Of South Carolina |
Chimeric antigen receptor modified regulatory t cells for treating cancer
|